Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA559017
Max Phase: Preclinical
Molecular Formula: C23H30ClN3O
Molecular Weight: 363.51
Molecule Type: Small molecule
Associated Items:
ID: ALA559017
Max Phase: Preclinical
Molecular Formula: C23H30ClN3O
Molecular Weight: 363.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1C[C@]2(C)C(NCCCO)=Nc3ccccc3[C@@H]2N(C)c2ccccc21.Cl
Standard InChI: InChI=1S/C23H29N3O.ClH/c1-16-15-23(2)21(26(3)20-12-7-5-9-17(16)20)18-10-4-6-11-19(18)25-22(23)24-13-8-14-27;/h4-7,9-12,16,21,27H,8,13-15H2,1-3H3,(H,24,25);1H/t16?,21-,23-;/m0./s1
Standard InChI Key: FOLGEMRUEVBXER-DWODVSLYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 363.51 | Molecular Weight (Monoisotopic): 363.2311 | AlogP: 4.39 | #Rotatable Bonds: 3 |
Polar Surface Area: 47.86 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.50 | CX LogP: 4.00 | CX LogD: 3.66 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.80 | Np Likeness Score: 0.24 |
1. Eifler-Lima V, Uriac P, Huet J, Jenkins T, Thurston D. (1995) Relationship between cytotoxicity and DNA-binding affinity of amidine derivatives of tetrahydroquino[4,3-b][1]benzazepines and tetrahydrobenzo[k]naphthyridines, 5 (24): [10.1016/0960-894X(95)00526-9] |
Source(1):